We subsequently detected CNVs in the CDK4, CDKN2A, and CDKN2B genes from plasma of MM patients (N = 60), including 46 patients with present primary tumor and 14 patients with present metastases, at the time of peripheral blood collection. This evidence concerns the gene CDK4 and Miyoshi myopathy.